IL6 and COVID-19: In the recently published meta-analysis by Gioia et al., nine risk factors for CAPA were identified including chronic liver disease, neurological malignancy, chronic obstructive pulmonary disease, cerebrovascular disease and diabetes, as well as mechanical ventilation, the use of renal replacement therapy, the treatment of COVID-19 with interleukin-6 inhibitors and the treatment of COVID-19 with corticosteroids.